Consequently, significant reductions in fibronectin, collagen type I, α-SMA, TIMP-1 and IL-6 were observed in TGF-β-treated SSc fibroblasts following treatment with CCN2-targeting siRNA. The gene discussed is TIMP1; the disease is systemic sclerosis.